Skip to main content
. 2019 Mar 15;39(3):BSR20180934. doi: 10.1042/BSR20180934

Figure 2. Expression of selected miRNAs in the population study.

Figure 2

(A) Differential expression of mir-154-5p (left), mir-182-5p (middle), and mir-6855-5p (right) in BAG3+/DCM+ patients (DCM) compared with asymptomatic BAG3+/DCM- individuals (Control). (Mean ± SD, *P<0.05 mir-154-5p DCM vs Control. *P<0.01 mir-182-5p DCM versus Control. *P<0.01 mir-6855-5p DCM versus Control). (B) Differential expression of mir-154-5p, mir-182-5p, and mir-6855-5p in males (M) and females (F) BAG3+/DCM+ patients (DCM) compared with males (M) and females (F) BAG3+/DCM- individuals (C)). (n=21 Mean ± SD). (C) Differential expression of mir-154-5p, mir-182-5p, and mir-6855-5p between males and females with decreased LEVF (LVEF<50%).